Amarin Corp Plc (AMRN)

[Sam81]

TRx Breakeven Level:
As per JT in the conf call "so off of last year's sort of December prescription levels, we had commented that, at that point in time, we needed to roughly double our prescription growth in order for us to breakeven on a commercial basis.
And I define commercial basis as being our cost excluding our R&D costs. And that guidance hasn't changed at this juncture."

2-Jan-15=9,516
26-Dec-14=8,508
19-Dec-14=10,539

Fair level would be around 20K for BEven on a commercial basis. Few extra thousand in TRx to include the R&D Costs